nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00208	0.00208	CcSEcCtD
Labetalol—Dyspnoea—Ifosfamide—testicular cancer	0.00208	0.00208	CcSEcCtD
Labetalol—Somnolence—Ifosfamide—testicular cancer	0.00208	0.00208	CcSEcCtD
Labetalol—Liver function test abnormal—Methotrexate—testicular cancer	0.00208	0.00208	CcSEcCtD
Labetalol—Discomfort—Cisplatin—testicular cancer	0.00208	0.00208	CcSEcCtD
Labetalol—Affect lability—Epirubicin—testicular cancer	0.00207	0.00207	CcSEcCtD
Labetalol—Vomiting—Vinblastine—testicular cancer	0.00206	0.00206	CcSEcCtD
Labetalol—Malaise—Etoposide—testicular cancer	0.00204	0.00204	CcSEcCtD
Labetalol—Vertigo—Etoposide—testicular cancer	0.00203	0.00203	CcSEcCtD
Labetalol—Headache—Vinblastine—testicular cancer	0.00203	0.00203	CcSEcCtD
Labetalol—Body temperature increased—Dactinomycin—testicular cancer	0.00202	0.00202	CcSEcCtD
Labetalol—Abdominal pain—Dactinomycin—testicular cancer	0.00202	0.00202	CcSEcCtD
Labetalol—Fatigue—Ifosfamide—testicular cancer	0.00201	0.00201	CcSEcCtD
Labetalol—Oedema—Cisplatin—testicular cancer	0.00201	0.00201	CcSEcCtD
Labetalol—Anaphylactic shock—Cisplatin—testicular cancer	0.00201	0.00201	CcSEcCtD
Labetalol—Hypersensitivity—Bleomycin—testicular cancer	0.00201	0.00201	CcSEcCtD
Labetalol—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Labetalol—Constipation—Ifosfamide—testicular cancer	0.002	0.002	CcSEcCtD
Labetalol—Pain—Ifosfamide—testicular cancer	0.002	0.002	CcSEcCtD
Labetalol—Hypoglycaemia—Doxorubicin—testicular cancer	0.002	0.002	CcSEcCtD
Labetalol—Cardiac failure—Doxorubicin—testicular cancer	0.002	0.002	CcSEcCtD
Labetalol—Mood swings—Epirubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Labetalol—Loss of consciousness—Etoposide—testicular cancer	0.00199	0.00199	CcSEcCtD
Labetalol—Lethargy—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Labetalol—Asthenia—Bleomycin—testicular cancer	0.00196	0.00196	CcSEcCtD
Labetalol—Hypertension—Etoposide—testicular cancer	0.00195	0.00195	CcSEcCtD
Labetalol—Hyperhidrosis—Cisplatin—testicular cancer	0.00195	0.00195	CcSEcCtD
Labetalol—Liver function test abnormal—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Labetalol—Pruritus—Bleomycin—testicular cancer	0.00193	0.00193	CcSEcCtD
Labetalol—Feeling abnormal—Ifosfamide—testicular cancer	0.00193	0.00193	CcSEcCtD
Labetalol—Nausea—Vinblastine—testicular cancer	0.00192	0.00192	CcSEcCtD
Labetalol—Orthostatic hypotension—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Labetalol—Abdominal pain upper—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Labetalol—Affect lability—Doxorubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Labetalol—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00191	0.00191	CcSEcCtD
Labetalol—Discomfort—Etoposide—testicular cancer	0.0019	0.0019	CcSEcCtD
Labetalol—Hypotension—Cisplatin—testicular cancer	0.00188	0.00188	CcSEcCtD
Labetalol—Hypersensitivity—Dactinomycin—testicular cancer	0.00188	0.00188	CcSEcCtD
Labetalol—Confusional state—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Labetalol—Urticaria—Ifosfamide—testicular cancer	0.00186	0.00186	CcSEcCtD
Labetalol—Abdominal pain—Ifosfamide—testicular cancer	0.00185	0.00185	CcSEcCtD
Labetalol—Body temperature increased—Ifosfamide—testicular cancer	0.00185	0.00185	CcSEcCtD
Labetalol—Anaphylactic shock—Etoposide—testicular cancer	0.00184	0.00184	CcSEcCtD
Labetalol—Mood swings—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Labetalol—Asthenia—Dactinomycin—testicular cancer	0.00183	0.00183	CcSEcCtD
Labetalol—Dysuria—Methotrexate—testicular cancer	0.00182	0.00182	CcSEcCtD
Labetalol—Paraesthesia—Cisplatin—testicular cancer	0.00181	0.00181	CcSEcCtD
Labetalol—Liver function test abnormal—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Labetalol—Dyspnoea—Cisplatin—testicular cancer	0.0018	0.0018	CcSEcCtD
Labetalol—Erectile dysfunction—Methotrexate—testicular cancer	0.00179	0.00179	CcSEcCtD
Labetalol—Hyperhidrosis—Etoposide—testicular cancer	0.00178	0.00178	CcSEcCtD
Labetalol—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Labetalol—Abdominal pain upper—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Labetalol—Angina pectoris—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Labetalol—Diarrhoea—Dactinomycin—testicular cancer	0.00174	0.00174	CcSEcCtD
Labetalol—Vomiting—Bleomycin—testicular cancer	0.00174	0.00174	CcSEcCtD
Labetalol—Drowsiness—Methotrexate—testicular cancer	0.00173	0.00173	CcSEcCtD
Labetalol—Depression—Methotrexate—testicular cancer	0.00173	0.00173	CcSEcCtD
Labetalol—Hypotension—Etoposide—testicular cancer	0.00172	0.00172	CcSEcCtD
Labetalol—Rash—Bleomycin—testicular cancer	0.00172	0.00172	CcSEcCtD
Labetalol—Pain—Cisplatin—testicular cancer	0.00172	0.00172	CcSEcCtD
Labetalol—Dermatitis—Bleomycin—testicular cancer	0.00172	0.00172	CcSEcCtD
Labetalol—Hypersensitivity—Ifosfamide—testicular cancer	0.00172	0.00172	CcSEcCtD
Labetalol—Dysuria—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Labetalol—Asthenia—Ifosfamide—testicular cancer	0.00168	0.00168	CcSEcCtD
Labetalol—Sweating—Methotrexate—testicular cancer	0.00166	0.00166	CcSEcCtD
Labetalol—Feeling abnormal—Cisplatin—testicular cancer	0.00166	0.00166	CcSEcCtD
Labetalol—Paraesthesia—Etoposide—testicular cancer	0.00166	0.00166	CcSEcCtD
Labetalol—Pruritus—Ifosfamide—testicular cancer	0.00165	0.00165	CcSEcCtD
Labetalol—Dyspnoea—Etoposide—testicular cancer	0.00164	0.00164	CcSEcCtD
Labetalol—Somnolence—Etoposide—testicular cancer	0.00164	0.00164	CcSEcCtD
Labetalol—Angina pectoris—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Labetalol—Epistaxis—Methotrexate—testicular cancer	0.00163	0.00163	CcSEcCtD
Labetalol—Nausea—Bleomycin—testicular cancer	0.00162	0.00162	CcSEcCtD
Labetalol—Drowsiness—Epirubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Labetalol—Vomiting—Dactinomycin—testicular cancer	0.00162	0.00162	CcSEcCtD
Labetalol—Agranulocytosis—Methotrexate—testicular cancer	0.00162	0.00162	CcSEcCtD
Labetalol—Rash—Dactinomycin—testicular cancer	0.00161	0.00161	CcSEcCtD
Labetalol—Diarrhoea—Ifosfamide—testicular cancer	0.0016	0.0016	CcSEcCtD
Labetalol—Body temperature increased—Cisplatin—testicular cancer	0.00159	0.00159	CcSEcCtD
Labetalol—Fatigue—Etoposide—testicular cancer	0.00159	0.00159	CcSEcCtD
Labetalol—Jaundice—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Labetalol—Pain—Etoposide—testicular cancer	0.00158	0.00158	CcSEcCtD
Labetalol—Constipation—Etoposide—testicular cancer	0.00158	0.00158	CcSEcCtD
Labetalol—Dysuria—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Labetalol—Hepatitis—Methotrexate—testicular cancer	0.00156	0.00156	CcSEcCtD
Labetalol—Sweating—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Labetalol—Dizziness—Ifosfamide—testicular cancer	0.00154	0.00154	CcSEcCtD
Labetalol—Epistaxis—Epirubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Labetalol—Feeling abnormal—Etoposide—testicular cancer	0.00152	0.00152	CcSEcCtD
Labetalol—Nausea—Dactinomycin—testicular cancer	0.00151	0.00151	CcSEcCtD
Labetalol—Agranulocytosis—Epirubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Labetalol—Gastrointestinal pain—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Labetalol—Drowsiness—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Labetalol—Visual impairment—Methotrexate—testicular cancer	0.0015	0.0015	CcSEcCtD
Labetalol—Vomiting—Ifosfamide—testicular cancer	0.00149	0.00149	CcSEcCtD
Labetalol—Hypersensitivity—Cisplatin—testicular cancer	0.00148	0.00148	CcSEcCtD
Labetalol—Bradycardia—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Labetalol—Rash—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Labetalol—Dermatitis—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Labetalol—Urticaria—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Labetalol—Jaundice—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Labetalol—Abdominal pain—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Labetalol—Body temperature increased—Etoposide—testicular cancer	0.00146	0.00146	CcSEcCtD
Labetalol—Hepatitis—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Labetalol—Hypoaesthesia—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Labetalol—Asthenia—Cisplatin—testicular cancer	0.00144	0.00144	CcSEcCtD
Labetalol—Sweating—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Labetalol—Oedema peripheral—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Labetalol—Epistaxis—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Labetalol—Visual impairment—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Labetalol—Agranulocytosis—Doxorubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Labetalol—Nausea—Ifosfamide—testicular cancer	0.00139	0.00139	CcSEcCtD
Labetalol—Diarrhoea—Cisplatin—testicular cancer	0.00138	0.00138	CcSEcCtD
Labetalol—Alopecia—Methotrexate—testicular cancer	0.00137	0.00137	CcSEcCtD
Labetalol—Bradycardia—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Labetalol—Mental disorder—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Labetalol—Hypersensitivity—Etoposide—testicular cancer	0.00136	0.00136	CcSEcCtD
Labetalol—Erythema—Methotrexate—testicular cancer	0.00135	0.00135	CcSEcCtD
Labetalol—Flushing—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Labetalol—Hepatitis—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Labetalol—Hypoaesthesia—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Labetalol—Oedema peripheral—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Labetalol—Asthenia—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Labetalol—Pruritus—Etoposide—testicular cancer	0.00131	0.00131	CcSEcCtD
Labetalol—Visual impairment—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Labetalol—Alopecia—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Labetalol—Vomiting—Cisplatin—testicular cancer	0.00128	0.00128	CcSEcCtD
Labetalol—Vision blurred—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Labetalol—Mental disorder—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Labetalol—Rash—Cisplatin—testicular cancer	0.00127	0.00127	CcSEcCtD
Labetalol—Dermatitis—Cisplatin—testicular cancer	0.00127	0.00127	CcSEcCtD
Labetalol—Erythema—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Labetalol—Diarrhoea—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Labetalol—Ill-defined disorder—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Labetalol—Flushing—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Labetalol—Malaise—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Labetalol—Dizziness—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Labetalol—Muscle spasms—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Labetalol—Vertigo—Methotrexate—testicular cancer	0.00122	0.00122	CcSEcCtD
Labetalol—Nausea—Cisplatin—testicular cancer	0.0012	0.0012	CcSEcCtD
Labetalol—Vision blurred—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Labetalol—Alopecia—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Labetalol—Mental disorder—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Labetalol—Ill-defined disorder—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Labetalol—Vomiting—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Labetalol—Erythema—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Labetalol—Rash—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Labetalol—Dermatitis—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Labetalol—Headache—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Labetalol—Malaise—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Labetalol—Discomfort—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Labetalol—Vertigo—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Labetalol—Syncope—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Labetalol—Muscle spasms—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Labetalol—Palpitations—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Labetalol—Confusional state—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Labetalol—Loss of consciousness—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Labetalol—Anaphylactic shock—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Labetalol—Vision blurred—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Labetalol—Nausea—Etoposide—testicular cancer	0.0011	0.0011	CcSEcCtD
Labetalol—Hypertension—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Labetalol—Ill-defined disorder—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Labetalol—Hyperhidrosis—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Labetalol—Discomfort—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Labetalol—Malaise—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Labetalol—Vertigo—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Labetalol—Syncope—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Labetalol—Confusional state—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Labetalol—Palpitations—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Labetalol—Oedema—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Labetalol—Anaphylactic shock—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Labetalol—Hypotension—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Labetalol—Loss of consciousness—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Labetalol—Shock—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Labetalol—Hypertension—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Labetalol—Hyperhidrosis—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Labetalol—Paraesthesia—Methotrexate—testicular cancer	0.000992	0.000992	CcSEcCtD
Labetalol—Discomfort—Doxorubicin—testicular cancer	0.000986	0.000986	CcSEcCtD
Labetalol—Dyspnoea—Methotrexate—testicular cancer	0.000985	0.000985	CcSEcCtD
Labetalol—Somnolence—Methotrexate—testicular cancer	0.000982	0.000982	CcSEcCtD
Labetalol—Dyspepsia—Methotrexate—testicular cancer	0.000973	0.000973	CcSEcCtD
Labetalol—Hypotension—Epirubicin—testicular cancer	0.000966	0.000966	CcSEcCtD
Labetalol—Confusional state—Doxorubicin—testicular cancer	0.000965	0.000965	CcSEcCtD
Labetalol—Anaphylactic shock—Doxorubicin—testicular cancer	0.000957	0.000957	CcSEcCtD
Labetalol—Oedema—Doxorubicin—testicular cancer	0.000957	0.000957	CcSEcCtD
Labetalol—Fatigue—Methotrexate—testicular cancer	0.000953	0.000953	CcSEcCtD
Labetalol—Pain—Methotrexate—testicular cancer	0.000945	0.000945	CcSEcCtD
Labetalol—Shock—Doxorubicin—testicular cancer	0.000941	0.000941	CcSEcCtD
Labetalol—Paraesthesia—Epirubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Labetalol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000925	0.000925	CcSEcCtD
Labetalol—Dyspnoea—Epirubicin—testicular cancer	0.000922	0.000922	CcSEcCtD
Labetalol—Somnolence—Epirubicin—testicular cancer	0.000919	0.000919	CcSEcCtD
Labetalol—Feeling abnormal—Methotrexate—testicular cancer	0.000911	0.000911	CcSEcCtD
Labetalol—Dyspepsia—Epirubicin—testicular cancer	0.00091	0.00091	CcSEcCtD
Labetalol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000904	0.000904	CcSEcCtD
Labetalol—Hypotension—Doxorubicin—testicular cancer	0.000894	0.000894	CcSEcCtD
Labetalol—Fatigue—Epirubicin—testicular cancer	0.000892	0.000892	CcSEcCtD
Labetalol—Pain—Epirubicin—testicular cancer	0.000884	0.000884	CcSEcCtD
Labetalol—Constipation—Epirubicin—testicular cancer	0.000884	0.000884	CcSEcCtD
Labetalol—Urticaria—Methotrexate—testicular cancer	0.000878	0.000878	CcSEcCtD
Labetalol—Abdominal pain—Methotrexate—testicular cancer	0.000874	0.000874	CcSEcCtD
Labetalol—Body temperature increased—Methotrexate—testicular cancer	0.000874	0.000874	CcSEcCtD
Labetalol—Paraesthesia—Doxorubicin—testicular cancer	0.000859	0.000859	CcSEcCtD
Labetalol—Dyspnoea—Doxorubicin—testicular cancer	0.000853	0.000853	CcSEcCtD
Labetalol—Feeling abnormal—Epirubicin—testicular cancer	0.000852	0.000852	CcSEcCtD
Labetalol—Somnolence—Doxorubicin—testicular cancer	0.000851	0.000851	CcSEcCtD
Labetalol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Labetalol—Dyspepsia—Doxorubicin—testicular cancer	0.000842	0.000842	CcSEcCtD
Labetalol—Fatigue—Doxorubicin—testicular cancer	0.000825	0.000825	CcSEcCtD
Labetalol—Urticaria—Epirubicin—testicular cancer	0.000822	0.000822	CcSEcCtD
Labetalol—Constipation—Doxorubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Labetalol—Pain—Doxorubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Labetalol—Abdominal pain—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Labetalol—Body temperature increased—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Labetalol—Hypersensitivity—Methotrexate—testicular cancer	0.000814	0.000814	CcSEcCtD
Labetalol—Asthenia—Methotrexate—testicular cancer	0.000793	0.000793	CcSEcCtD
Labetalol—Feeling abnormal—Doxorubicin—testicular cancer	0.000789	0.000789	CcSEcCtD
Labetalol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000783	0.000783	CcSEcCtD
Labetalol—Pruritus—Methotrexate—testicular cancer	0.000782	0.000782	CcSEcCtD
Labetalol—Hypersensitivity—Epirubicin—testicular cancer	0.000762	0.000762	CcSEcCtD
Labetalol—Urticaria—Doxorubicin—testicular cancer	0.00076	0.00076	CcSEcCtD
Labetalol—Abdominal pain—Doxorubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Labetalol—Body temperature increased—Doxorubicin—testicular cancer	0.000756	0.000756	CcSEcCtD
Labetalol—Diarrhoea—Methotrexate—testicular cancer	0.000756	0.000756	CcSEcCtD
Labetalol—Asthenia—Epirubicin—testicular cancer	0.000742	0.000742	CcSEcCtD
Labetalol—Pruritus—Epirubicin—testicular cancer	0.000732	0.000732	CcSEcCtD
Labetalol—Dizziness—Methotrexate—testicular cancer	0.000731	0.000731	CcSEcCtD
Labetalol—Diarrhoea—Epirubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
Labetalol—Hypersensitivity—Doxorubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Labetalol—Vomiting—Methotrexate—testicular cancer	0.000703	0.000703	CcSEcCtD
Labetalol—Rash—Methotrexate—testicular cancer	0.000697	0.000697	CcSEcCtD
Labetalol—Dermatitis—Methotrexate—testicular cancer	0.000696	0.000696	CcSEcCtD
Labetalol—Headache—Methotrexate—testicular cancer	0.000692	0.000692	CcSEcCtD
Labetalol—Asthenia—Doxorubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Labetalol—Dizziness—Epirubicin—testicular cancer	0.000684	0.000684	CcSEcCtD
Labetalol—Pruritus—Doxorubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Labetalol—Vomiting—Epirubicin—testicular cancer	0.000658	0.000658	CcSEcCtD
Labetalol—Nausea—Methotrexate—testicular cancer	0.000656	0.000656	CcSEcCtD
Labetalol—Diarrhoea—Doxorubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Labetalol—Rash—Epirubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Labetalol—Dermatitis—Epirubicin—testicular cancer	0.000651	0.000651	CcSEcCtD
Labetalol—Headache—Epirubicin—testicular cancer	0.000648	0.000648	CcSEcCtD
Labetalol—Dizziness—Doxorubicin—testicular cancer	0.000633	0.000633	CcSEcCtD
Labetalol—Nausea—Epirubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Labetalol—Vomiting—Doxorubicin—testicular cancer	0.000608	0.000608	CcSEcCtD
Labetalol—Rash—Doxorubicin—testicular cancer	0.000603	0.000603	CcSEcCtD
Labetalol—Dermatitis—Doxorubicin—testicular cancer	0.000603	0.000603	CcSEcCtD
Labetalol—Headache—Doxorubicin—testicular cancer	0.000599	0.000599	CcSEcCtD
Labetalol—Nausea—Doxorubicin—testicular cancer	0.000568	0.000568	CcSEcCtD
